RPMGX
Price
$109.07
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
VMCCX
Price
$52.85
Change
-$0.43 (-0.81%)
Updated
Sep 20 closing price
Ad is loading...

RPMGX vs VMCCX

Header iconRPMGX vs VMCCX Comparison
Open Charts RPMGX vs VMCCXBanner chart's image
T. Rowe Price Mid-Cap Growth
Price$109.07
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
Virtus KAR Mid-Cap Core C
Price$52.85
Change-$0.43 (-0.81%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RPMGX vs VMCCX Comparison Chart
Loading...
VS
RPMGX vs. VMCCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPMGX is a StrongBuy and VMCCX is a Buy.

FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.4B vs. VMCCX (2.89B). RPMGX pays higher dividends than VMCCX: RPMGX (0.05) vs VMCCX (0.00). RPMGX was incepted earlier than VMCCX: RPMGX (32 years) vs VMCCX (15 years). RPMGX (21.70) and VMCCX (21.00) have comparable annual turnover. RPMGX (2500) and VMCCX (2500) have matching initial minimum investment requirements. VMCCX annual gain was more profitable for investors over the last year : 16.26 vs. RPMGX (14.65). VMCCX return over 5 years is better than : 60.98 vs. RPMGX (14.51).
RPMGXVMCCXRPMGX / VMCCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years15 years-
Gain YTD9.0267.637118%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B2.89B1,087%
Annual Yield % from dividends0.050.00-
Returns for 1 year14.6516.2690%
Returns for 3 years-13.815.24-264%
Returns for 5 years14.5160.9824%
Returns for 10 years43.29165.1826%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CEAD6.90-0.10
-1.43%
CEA Industries
ELF112.91-1.68
-1.47%
elf Beauty
WAFD35.21-1.20
-3.30%
WaFd
PKST15.04-0.67
-4.26%
Peakstone Realty Trust
CHRS1.02-0.11
-9.73%
Coherus BioSciences